Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Title
Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months
Authors
Keywords
-
Journal
Clinical Gastroenterology and Hepatology
Volume 8, Issue 7, Pages 600-609
Publisher
Elsevier BV
Online
2010-02-02
DOI
10.1016/j.cgh.2010.01.014

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now